Seth Kiernan - Insider Non-Derivative Transactions at LEXICON PHARMACEUTICALS, INC. (LXRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 28, 2023, Seth Kiernan's relationship to LEXICON PHARMACEUTICALS, INC. (LXRX) is Officer (VP, Chief Commercial Officer) (VP, Chief Commercial Officer), and currently has 64,949 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LXRX insiders.
Data Source: SEC.
Seth Kiernan - Insider Non-Derivative Transactions at LXRX
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 1, 2023 | M -- (Common Stock) | 14,833 | 0 | 36,700 |
| Mar 1, 2023 | M -- (Common Stock) | 5,286 | 0 | 41,986 |
| Mar 1, 2023 | F -- (Common Stock) | 11,813 | 2.17 | 53,136 |
| Mar 1, 2023 | M -- (Common Stock) | 22,963 | 0 | 64,949 |
Items per page:
1 – 4 of 4